Human anti-tau antibodies
US9598484B2 · kind B2 · utility
12Cited by
2References
182Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 20, 2013 |
| Grant date | Mar 21, 2017 |
| Priority date | — |
| Expiry date | Dec 20, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2814
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are human tau-specific antibodies as well as fragments, derivatives and variants thereof as well as methods related thereto. Assays, kits, and solid supports related to antibodies specific for tau are also disclosed. The antibody, immunoglobulin chain(s), as well as binding fragments, derivatives and variants thereof can be used in pharmaceutical and diagnostic compositions for tau targeted immunotherapy and diagnosis, respectively.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.